Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with ...
Leadership
Stelios Papadopoulos Ph.D.Founder
Co-Founder & Independent Chair of the Board
Michael M. Morrissey Ph.D.
CEO, President & Director
Christopher J. Senner
Executive VP & CFO
Brenda J. Hefti J.D., Ph.D.
Senior VP & General Counsel
Dana T. Aftab Ph.D.
Executive Vice President of Research & Development
